相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
Ji Feng et al.
ACTA PHARMACOLOGICA SINICA (2021)
Ibrutinib Potentiates Antihepatocarcinogenic Efficacy of Sorafenib by Targeting EGFR in Tumor Cells and BTK in Immune Cells in the Stroma
Cho-Hao Lin et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Molecular therapies for HCC: Looking outside the box
Sandrine Faivre et al.
JOURNAL OF HEPATOLOGY (2020)
Protein Kinase B Inactivation Is Associated with Magnolol-Enhanced Therapeutic Efficacy of Sorafenib in Hepatocellular Carcinoma In Vitro and In Vivo
Jiann-Hwa Chen et al.
CANCERS (2020)
Targeting autophagy enhances the anticancer effect of artemisinin and its derivatives
Xin Sun et al.
MEDICINAL RESEARCH REVIEWS (2019)
Artesunate promotes sensitivity to sorafenib in hepatocellular carcinoma
Wu Jing et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
Artemisinin, the Magic Drug Discovered from Traditional Chinese Medicine
Jigang Wang et al.
ENGINEERING (2019)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence
Dong-Hwan Jung et al.
LIVER TRANSPLANTATION (2018)
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Antrodia cinnamomea boosts the anti-tumor activity of sorafenib in xenograft models of human hepatocellular carcinoma
Wei-De Wu et al.
SCIENTIFIC REPORTS (2018)
Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate
Anna L. Greenshields et al.
MOLECULAR CARCINOGENESIS (2017)
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Sebastian Doll et al.
NATURE CHEMICAL BIOLOGY (2017)
Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
Jong-Lyel Roh et al.
REDOX BIOLOGY (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib
Aline Houessinon et al.
MOLECULAR CANCER (2016)
CCAAT/Enhancer Binding Protein α Predicts Poorer Prognosis and Prevents Energy Starvation-Induced Cell Death in Hepatocellular Carcinoma
Guo-Dong Lu et al.
HEPATOLOGY (2015)
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
Jigang Wang et al.
NATURE COMMUNICATIONS (2015)
Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells
Harish Chandra Pal et al.
ONCOTARGET (2015)
Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis
Da Eun Jeong et al.
ONCOTARGET (2015)
Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent
Yves-Paul Vandewynckel et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2014)
Artesunate Induces Cell Death in Human Cancer Cells via Enhancing Lysosomal Function and Lysosomal Degradation of Ferritin
Nai-Di Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis
Scott J. Dixon et al.
ELIFE (2014)
Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion
Jing Zhou et al.
CELL RESEARCH (2013)
Medical therapies for hepatocellular carcinoma: a critical view of the evidence
Augusto Villanueva et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib
Thomas Yau et al.
ONCOLOGIST (2011)
Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo
Gang Wei et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation
Kuen-Feng Chen et al.
JOURNAL OF HEPATOLOGY (2010)
Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis
Ikuhiko Nakase et al.
CANCER LETTERS (2009)
Induction of Bim Expression Contributes to the Antitumor Synergy Between Sorafenib and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Inhibitor CI-1040 in Hepatocellular Carcinoma
Da-Liang Ou et al.
CLINICAL CANCER RESEARCH (2009)
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo
Pippa Newell et al.
JOURNAL OF HEPATOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
分享论文
